Greg Hughes is a process chemist with extensive experience in developing cost-effective and environmentally sustainable manufacturing processes for the pharmaceutical industry. Hughes has leveraged his expertise in enabling technologies, such as biocatalysis, catalysis, flow chemistry, and automation, to create business value.

Hughes received his Bachelor of Science degree in Chemistry from the University of New Brunswick, followed by his Doctor of Philosophy degree in Organic Chemistry from the University of Toronto. He then pursued post-doctoral studies in Asymmetric Catalysis at MIT.

Hughes has held several roles in his career, including Senior Principal Scientist at Merck, Vice President of Business Development at Codexis Inc., Executive Director of Enabling Technologies, Process Chemistry at Merck, and Research Chemist at both Merck Frost Center and Fine Chemicals Division of Diagnostic Chemicals Ltd. He has also contributed to research as an undergraduate researcher at Merck Frost and a laboratory technician at the New Brunswick Department of the Environment.

Overall, Hughes's goal is to innovate with and adopt fantastic technologies to create value for organizations and the industry.